GCS is an enzyme involved in sphingolipid metabolism that transfers glucose from UDP-glucose (uridine diphosphate- glucose) to ceramide producing glucosylceramides, and its implications in the development of cancer drug resistance have garnered considerable interest in the past few years [72,73,74,75,76]. This evidence concerns the gene UGCG and cancer.